CONDENSED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balances at Oct. 23, 2013
Increase (Decrease) in Stockholders' Equity
Sale of common stock to Sponsor on November 20, 2013 at approximately $.004 per share	$ 604	$ 24,396	$ 0	$ 25,000
Sale of common stock to Sponsor on November 20, 2013 at approximately $.004 per share (in shares)	6,037,500
Balances at Dec. 31, 2013	604	24,396		25,000
Balances (in shares) at Dec. 31, 2013	6,037,500
Increase (Decrease) in Stockholders' Equity
Sale of 21,000,000 units on February 19, 2014	2,100	209,997,900		210,000,000
Sale of 21,000,000 units on February 19, 2014 (in shares)	21,000,000
Sale of 5,950,000 warrants to Sponsor on February 19, 2014		5,950,000		5,950,000
Reclassification of shares subject to possible redemption, at redemption value, on February 19, 2014	(1,988)	(198,814,432)		(198,816,420)
Reclassification of shares subject to possible redemption, at redemption value, on February 19, 2014 (in shares)	(19,881,642)
Sale of 1,050,000 units on March 13, 2014, pursuant to the underwriters' partial exercise of their over-allotment option	105	10,499,895		10,500,000
Sale of 1,050,000 units on March 13, 2014, pursuant to the underwriters' partial exercise of their over-allotment option (in shares)	1,050,000
Sale of 210,000 warrants to Sponsor on March 13, 2014, pursuant to the underwriters' partial exercise of their over-allotment option		210,000		210,000
Forfeiture of Sponsor and independent directors shares on March 13, 2014, due to the underwriters' partial exercise of their over-allotment option	(53)	53
Forfeiture of Sponsor and independent directors shares on March 13, 2014, due to the underwriters' partial exercise of their over-allotment option (in shares)	(525,000)
Reclassification of shares subject to possible redemption, at redemption value, on March 13, 2014	(101)	(10,126,852)		(10,126,953)
Reclassification of shares subject to possible redemption, at redemption value, on March 13, 2014 (in shares)	(1,012,695)
Underwriters' discount and offering expenses		(12,741,617)		(12,741,617)
Change in proceeds subject to possible redemption	7	673,948		673,955
Change in proceeds subject to possible redemption (in shares)	67,395
Net income/(loss) attributable to common stockholders			(673,955)	(673,955)
Balances at Dec. 31, 2014	$ 674	$ 5,673,291	$ (673,955)	$ 5,000,010
Balances (in shares) at Dec. 31, 2014	6,735,558